Full Library
Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients
Resource type
Journal Article
Authors/contributors
- Samanta, Palash (Author)
- Clancy, Cornelius J (Author)
- Marini, Rachel V (Author)
- Rivosecchi, Ryan M (Author)
- McCreary, Erin K (Author)
- Shields, Ryan K (Author)
- Falcione, Bonnie A (Author)
- Viehman, Alex (Author)
- Sacha, Lauren (Author)
- Kwak, Eun Jeong (Author)
- Silveira, Fernanda P (Author)
- Sanchez, Pablo G (Author)
- Morrell, Matthew (Author)
- Clarke, Lloyd (Author)
- Nguyen, M Hong (Author)
Title
Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients
Abstract
Isavuconazole was as effective as and better tolerated than voriconazole in preventing invasive fungal infections (IFIs) after lung transplantation. Breakthrough IFIs occurred in 3% of patients receiving isavuconazole or voriconazole prophylaxis. IFIs were associated with increased mortality and longer hospitalizations.
Publication
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Date
2020-5-28
Volume
73
Issue
3
Pages
416-426
Journal Abbr
Clin Infect Dis
Accessed
8/18/21, 3:07 PM
ISSN
1058-4838
Library Catalog
PubMed Central
Extra
PMID: 32463873
PMCID: PMC8326536
Citation
Samanta, P., Clancy, C. J., Marini, R. V., Rivosecchi, R. M., McCreary, E. K., Shields, R. K., Falcione, B. A., Viehman, A., Sacha, L., Kwak, E. J., Silveira, F. P., Sanchez, P. G., Morrell, M., Clarke, L., & Nguyen, M. H. (2020). Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 73(3), 416–426. https://doi.org/10.1093/cid/ciaa652
DRUGS AND THERAPIES
SOLID ORGANS AND MCSS
Link to this record